Transient narcolepsy-cataplexy syndrome after discontinuation of the antidepressant venlafaxine.
Nissen
Christoph
C
Feige
Bernd
B
Nofzinger
Eric
E
Riemann
Dieter
D
Berger
Mathias
M
Voderholzer
Ulrich
U
D000328:Adult; D001714:Bipolar Disorder / Q000188:drug therapy*; D003511:Cyclohexanols / Q000009:adverse effects*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D019263:Dysthymic Disorder / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009290:Narcolepsy / Q000139:chemically induced* / Q000175:diagnosis; D017286:Polysomnography; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis / Q000209:etiology*; D017211:Treatment Failure; D000069470:Venlafaxine Hydrochloride
D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride